Matthew Poirier

Matthew Poirier is a Senior Financial Analyst specializing in Cell Culture at Cytiva since March 2023, previously serving as a USCAN Upstream Commercial Finance Analyst. Prior experience includes roles as an Investor Relations Consulting Analyst at Alpha IR Group and positions at Dell Technologies, including ISG Pricing and Storage CoC Finance within the Financial Development Program. Matthew also managed a $1.8 million portfolio as Portfolio Manager for the Archway Investment Fund at Bryant University. Early career experiences involved financial analysis internships at Dell Technologies and Fidelity Investments, field marketing at NESCOR, and customer service at Walgreens. Matthew holds a Bachelor's degree in Finance from Bryant University, completed in 2021.